Efficacy and Safety of BCD-100 (Anti-PD-1) in Combination With Platinum-Based Chemotherapy With and Without Bevacizumab as First-Line Treatment of Subjects With Advanced Cervical Cancer (FERMATA)

Clinical trial NCT03912415 · UNKNOWN

Trial details

NCT number: NCT03912415
Sponsor: Biocad
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Cervical Cancer

Start date: 2019-10-01
Primary completion: 2024-12-01
Enrollment: 316

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.